Table 5 Estimated means of primary and secondary outcomes from the multilevel model at pretreatment, posttreatment and follow-ups
pretreatment (n = 24) | posttreatment (n = 16) | 1-month follow-up (n = 16) | 3-month follow-up (n = 16) | 6-month follow-up (n = 14) | 12-month follow-up (n = 13) | post follow-up (n = 13) | |
|---|---|---|---|---|---|---|---|
Mean [95% CI] | Mean [95% CI] | Mean [95% CI] | Mean [95% CI] | Mean [95% CI] | Mean [95% CI] | Mean [95% CI] | |
Primary outcome | |||||||
WBQ | 2.81 [2.06, 3.74] | 0.83 [0.54, 1.17] | 0.84 [0.56, 1.17] | 0.87 [0.60, 1.19] | 0.92 [0.63, 1.25] | 1.02 [0.62, 1.52] | 1.02 [0.61, 1.54] |
Secondary outcomes | |||||||
EDE-Q global score | 3.57 [3.07, 4.07] | 2.48 [1.92, 3.03] | – | – | 2.13 [1.65, 2.61] | – | 1.75 [1.15, 2.35] |
BMI-SDS | 1.29 [0.80, 1.78] | 1.14 [0.63, 1.65] | – | – | 1.13 [0.62, 1.65] | – | 1.18 [0.66, 1.70] |
BDI-FS | 6.06 [4.72, 7.39] | 2.55 [1.53, 3.58] | 2.54 [1.59, 3.49] | 2.50 [1.71, 3.28] | 2.44 [1.72, 3.15] | 2.32 [1.13, 3.50] | 2.31 [1.10, 3.53] |
ARS-D | 13.61 [10.24, 16.99] | 10.34 [6.64, 14.04] | – | – | 9.03 [5.69, 12.36] | – | 7.59 [3.68, 11.50] |